These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17401722)

  • 21. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
    Maurel S; Schreiber R; De Vry J
    Behav Pharmacol; 1998 Jul; 9(4):337-43. PubMed ID: 10065922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT(2C) antagonism blocks blood oxygen level-dependent pharmacological-challenge magnetic resonance imaging signal in rat brain areas related to feeding.
    Stark JA; McKie S; Davies KE; Williams SR; Luckman SM
    Eur J Neurosci; 2008 Jan; 27(2):457-65. PubMed ID: 18190518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
    Quérée P; Peters S; Sharp T
    Br J Pharmacol; 2009 Nov; 158(6):1477-85. PubMed ID: 19845681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.
    Pockros LA; Pentkowski NS; Conway SM; Ullman TE; Zwick KR; Neisewander JL
    Synapse; 2012 Dec; 66(12):989-1001. PubMed ID: 22886755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.
    Gleason SD; Lucaites VL; Shannon HE; Nelson DL; Leander JD
    Behav Pharmacol; 2001 Dec; 12(8):613-20. PubMed ID: 11856898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.
    Miranda F; Hong E; Sánchez H; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2003 Jan; 74(2):371-80. PubMed ID: 12479957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment.
    Campbell BM; Merchant KM
    Brain Res; 2003 Dec; 993(1-2):1-9. PubMed ID: 14642825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ; Mosher TM; Greenshaw AJ
    Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the discriminative stimulus effects of lorcaserin in rats.
    Serafine KM; Rice KC; France CP
    J Exp Anal Behav; 2016 Sep; 106(2):107-16. PubMed ID: 27640338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK; Evans DC
    Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.
    Scarlota LC; Harvey JA; Aloyo VJ
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):393-401. PubMed ID: 20652541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.